777. Deputy Aisling Dempsey asked the Minister for Health the reason tirzepatide (Mounjaro) is authorised for the treatment of type 2 diabetes but not covered by the medical card, long-term illness scheme or drugs payment scheme. [52993/26]
Topics / Medicinal Products
A subject heading for parliamentary questionsMedicinal Products
1,233 questions from 132 TDs, between 22 January 2025 and 22 October 2026.
1,233
questions
1,229 written, 4 oral
132
TDs have asked
11
parties and groups
Independents counted together
4
departments asked
Questions per month
The record holds no questions for August, when the Dáil does not sit.
Jan 2025Oct 2026
Show as a table
| Month | Questions |
|---|---|
| January 2025 | 17 |
| February 2025 | 66 |
| March 2025 | 28 |
| April 2025 | 35 |
| May 2025 | 43 |
| June 2025 | 58 |
| July 2025 | 56 |
| August 2025 | 0 |
| September 2025 | 36 |
| October 2025 | 38 |
| November 2025 | 58 |
| December 2025 | 27 |
| January 2026 | 18 |
| February 2026 | 70 |
| March 2026 | 142 |
| April 2026 | 87 |
| May 2026 | 156 |
| June 2026 | 127 |
| July 2026 | 82 |
| August 2026 | 0 |
| September 2026 | 62 |
| October 2026 | 27 |
Who asks, by party
The party each TD belonged to on the day, in alphabetical order. Parties differ a lot in size, and members of the Government answer questions rather than ask them, so this shows who raised it, not how much a party cares about it.
The TDs who asked most
Members of the Government answer questions rather than ask them. Each question counts once.
-
196
-
75
-
43
-
42
-
39
-
26
-
26
-
26
Asked of
Debated under the same heading
Debates whose official heading is exactly these words.
The questions
784. Deputy Jennifer Whitmore asked the Minister for Health if she will consider bringing trial adenomyosis drugs under the drug payment scheme or offering compensation for women who avail of these trial drugs; and if she will make a statement on the matter. [53005/26]
851. Deputy Pádraig O'Sullivan asked the Minister for Health the number of patients availing of the GMS medicines optimisation support service since its commencement on 1 June 2026; the number of patients previously in receipt of phased dispensing who have transitioned to the new service; and if she will make a statement on the matter. [53324/26]
852. Deputy Pádraig O'Sullivan asked the Minister for Health the projected full-year cost of the GMS medicines optimisation support service, including the €0.35 fee payable per GMS item dispensed and the €32.50 monthly enhanced medicines optimisation support fee, as agreed under the Community Pharmacy Agreement 2025; the amount paid out under each fee to date in 2026; and if she will make a statement on the matter. […
853. Deputy Pádraig O'Sullivan asked the Minister for Health if she will publish the PCRS-approved list of medicines that qualify a patient for the enhanced medicines optimisation support fee under the GMS medicines optimisation support service; the clinical criteria used to compile that list; whether the list will be kept under review; and if she will make a statement on the matter. [53326/26]
854. Deputy Pádraig O'Sullivan asked the Minister for Health the eligibility criteria applying to the GMS medicines optimisation support service for patients with cognitive or physical impairment, intellectual disability, or experiencing social exclusion including homelessness; the method by which eligibility is assessed and by whom; the appeal mechanism available where a patient is refused access; and if she will ma…
855. Deputy Pádraig O'Sullivan asked the Minister for Health the rationale for treating monitored dosage systems, commonly known as blister packs, as a last-resort option under the GMS medicines optimisation support service which commenced on 1 June 2026; her response to concerns that patients in residential care settings will no longer receive blister packs free of charge; the assessment her Department has carried o…
856. Deputy Pádraig O'Sullivan asked the Minister for Health whether patients in receipt of free phased dispensing or blister packs in August 2025 will retain that support indefinitely under the GMS medicines optimisation support service; the arrangements for new patients who would previously have qualified; and if she will make a statement on the matter. [53329/26]
857. Deputy Pádraig O'Sullivan asked the Minister for Health the number of community pharmacies onboarded to date to the national unused medicines return and disposal scheme provided for under the Community Pharmacy Agreement 2025; the target date for all pharmacies to be participating; and if she will make a statement on the matter. [53333/26]
858. Deputy Pádraig O'Sullivan asked the Minister for Health the reason Ireland did not operate a national collection system for unused medicines despite the obligation under Directive 2004/27/EC, in place since 2004; the steps taken to ensure the new scheme achieves full compliance with that Directive; and if she will make a statement on the matter. [53334/26]
859. Deputy Pádraig O'Sullivan asked the Minister for Health when the planned public awareness campaign on the return of unused medicines to pharmacies will launch; the budget allocated to that campaign; and if she will make a statement on the matter. [53335/26]
860. Deputy Pádraig O'Sullivan asked the Minister for Health whether the review of the national unused medicines return and disposal scheme scheduled after nine months of operation will be published; the metrics that will be used to evaluate the scheme, including tonnage of medicines collected and pharmacy participation rates; and if she will make a statement on the matter. [53336/26]
861. Deputy Pádraig O'Sullivan asked the Minister for Health the assessment her Department has made of the contribution of unused medicines in the home to accidental poisoning of children, self-harm and suicide risk; whether data on hospital presentations linked to accidental ingestion of medicines by children will be used to evaluate the impact of the national unused medicines return scheme; and if she will make a s…
228. Deputy Ann Graves asked the Minister for Health if she is aware of the use of sativex (nabiximols), a pharmaceutical-grade spray, or any other standardised cannabinoid extracts licensed and available to assist those withdrawing from cannabis use; and her views on the dual diagnosis services that are available for those experiencing cannabis addiction and mental health issues. [52110/26]
722. Deputy Sorca Clarke asked the Minister for Health the reason that a person (details supplied), who is a medical card holder and is pre diabetic, has been refused a drug prescribed by their GP; the financial supports that are available to this person in accessing this drug; and if she will make a statement on the matter. [50926/26]
727. Deputy Niamh Smyth asked the Minister for Health if she will urgently review the case of a person (details supplied); if she will provide an update on the pain management supports available to them in the interim period prior to their scheduled nerve block procedure; and if she will make a statement on the matter. [50954/26]
730. Deputy Sean Fleming asked the Minister for Health the reasoning behind the proposed changes to providing supplements that people require for their health without having to take prescribed drugs (details supplied); and if she will make a statement on the matter. [50958/26]
745. Deputy Danny Healy-Rae asked the Minister for Health for an update on a matter regarding prescription medication for a person (details supplied); and if she will make a statement on the matter. [51005/26]
746. Deputy Claire Kerrane asked the Minister for Health whether she intends to make a device (details supplied) reimbursable for people with diabetes type 2, as those with type 1 have access to reimbursement; and if she will make a statement on the matter. [51013/26]
755. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2415 of 9 June 2026, to provide the data on the number of pharmacy reimbursement claims adjusted and the number successfully appealed in each year from 2020 to date (details supplied).; and if she will make a statement on the matter. [51052/26]
756. Deputy Ken O'Flynn asked the Minister for Health whether the Primary Care Reimbursement Service holds a national dataset recording the number of pharmacy reimbursement claims adjusted and the number successfully appealed; and if no such dataset is held, to state this plainly; and if she will make a statement on the matter. [51053/26]
757. Deputy Ken O'Flynn asked the Minister for Health to set out the formal mechanism, if any, by which a pharmacy may appeal a rejected reimbursement claim; the average time to determination; the number and proportion of such appeals upheld in each year from 2020 to date; and if she will make a statement on the matter. [51054/26]
758. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2415 of 9 June 2026, to reconcile the figures provided in the reply, given that the difference between claims submitted (details supplied); and if she will make a statement on the matter. [51055/26]
759. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2415 of 9 June 2026, recording "eligibility expired" as the leading reason for pharmacy claim rejection in the years 2020 to 2022, peaking at 30,005 rejections in 2021; the assessment that has been made of the impact on patients dispensed medicines whose eligibility had lapsed at point of dispensing, including whether any such…
764. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2415 of 9 June 2026, to now provide those figures for each year, or to confirm that no such data is held by the Health Service Executive (details supplied). [51061/26]